Abnormal n-6 fatty acid metabolism in cystic fi brosis is caused by activation of AMP-activated protein kinase

Journal of Lipid Research

Volumn 55, Issue 7, 2014, Pages 1489-1497

  Umunakwe, Obi C ^a   Seegmiller, Adam C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine 5 monophosphateactivated protein kinase; Arachidonic acid; Fatty acid desaturase; Linoleic acid; Polyunsaturated fatty acid

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE BETA; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG; CFTR PROTEIN, HUMAN;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FATTY ACID METABOLISM; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL LINE; EPITHELIUM CELL; GENETICS; HUMAN; METABOLISM; PATHOLOGY; RESPIRATORY MUCOSA;

AMP-ACTIVATED PROTEIN KINASES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELL LINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; FATTY ACIDS, OMEGA-6; HUMANS; RESPIRATORY MUCOSA;

EID: 84904022653     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M050369     Document Type: Article

References (59)

1. O'Sullivan, B. P., and S. D. Freedman. 2009. Cystic fi brosis. Lancet. 373: 1891-1904.
2. Kerem, B., J. M. Rommens, J. A. Buchanan, D. Markiewicz, T. K. Cox, A. Chakravarti, M. Buchwald, and L. C. Tsui. 1989. Identifi cation of the cystic fi brosis gene: genetic analysis. Science. 245: 1073-1080.
3. Gadsby, D. C., P. Vergani, and L. Csanady. 2006. The ABC protein turned chloride channel whose failure causes cystic fi brosis. Nature. 440: 477-483.
4. Al-Turkmani, M. R., S. D. Freedman, and M. Laposata. 2007. Fatty acid alterations and n-3 fatty acid supplementation in cystic fi brosis. Prostaglandins Leukot. Essent. Fatty Acids. 77: 309-318.
5. Worgall, T. S. 2009. Lipid metabolism in cystic fi brosis. Curr. Opin. Clin. Nutr. Metab. Care. 12: 105-109.
6. Strandvik, B. 2010. Fatty acid metabolism in cystic fi brosis. Prostaglandins Leukot. Essent. Fatty Acids. 83: 121-129.
7. Freedman, S. D., P. G. Blanco, M. M. Zaman, J. C. Shea, M. Ollero, I. K. Hopper, D. A. Weed, A. Gelrud, M. M. Regan, M. Laposata, et al. 2004. Association of cystic fi brosis with abnormalities in fatty acid metabolism. N. Engl. J. Med. 350: 560-569.
8. Batal, I., M. B. Ericsoussi, J. E. Cluette-Brown, B. P. O'Sullivan, S. D. Freedman, J. E. Savaille, and M. Laposata. 2007. Potential utility of plasma fatty acid analysis in the diagnosis of cystic fi brosis. Clin. Chem. 53: 78-84.
9. Strandvik, B., E. Gronowitz, F. Enlund, T. Martinsson, and J. Wahlstrom. 2001. Essential fatty acid defi ciency in relation to genotype in patients with cystic fi brosis. J. Pediatr. 139: 650-655.
10. Olveira, G., A. Dorado, C. Olveira, A. Padilla, G. Rojo-Martinez, E. Garcia-Escobar, I. Gaspar, M. Gonzalo, and F. Soriguer. 2006. Serum phospholipid fatty acid profi le and dietary intake in an adult Mediterranean population with cystic fi brosis. Br. J. Nutr. 96: 343-349.
11. Van Biervliet, S., G. Vanbillemont, J. P. Van Biervliet, D. Declercq, E. Robberecht, and A. Christophe. 2007. Relation between fatty acid composition and clinical status or genotype in cystic fi brosis patients. Ann. Nutr. Metab. 51: 541-549.
12. Ollero, M., G. Astarita, I. C. Guerrera, I. Sermet-Gaudelus, S. Trudel, D. Piomelli, and A. Edelman. 2011. Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fi brosis patients. J. Lipid Res. 52: 1011-1022.
13. Freedman, S. D., M. H. Katz, E. M. Parker, M. Laposata, M. Y. Urman, and J, G. Alvarez. 1999. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fi brosis in cftr(-/-) mice. Proc. Natl. Acad. Sci. USA. 96: 13995-14000.
14. Guilbault, C., G. Wojewodka, Z. Saeed, M. Hajduch, E. Matouk, J. B. De Sanctis, and D. Radzioch. 2009. Cystic fi brosis fatty acid imbalance is linked to ceramide defi ciency and corrected by fenretinide. Am. J. Respir. Cell Mol. Biol. 41: 100-106.
15. Mimoun, M., T. C. Coste, J. Lebacq, P. Lebecque, P. Wallemacq, T. Leal, and M. Armand. 2009. Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fi brosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid. J. Nutr. 139: 2358-2364.
16. Al-Turkmani, M. R., C. Andersson, R. Alturkmani, W. Katrangi, J. E. Cluette-Brown, S. D. Freedman, and M. Laposata. 2008. A mechanism accounting for the low cellular level of linoleic acid in cystic fi brosis and its reversal by DHA. J. Lipid Res. 49: 1946-1954.
17. Andersson, C., M. R. Al-Turkmani, J. E. Savaille, R. Alturkmani, W. Katrangi, J. E. Cluette-Brown, M. M. Zaman, M. Laposata, and S. D. Freedman. 2008. Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. J. Lipid Res. 49: 1692-1700.
18. Nakamura, M. T., and T. Y. Nara. 2003. Essential fatty acid synthesis and its regulation in mammals. Prostaglandins Leukot. Essent. Fatty Acids. 68: 145-150.
19. Njoroge, S. W., A. C. Seegmiller, W. Katrangi, and M. Laposata. 2011. Increased-5-and-6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fi brosis. Biochim. Biophys. Acta. 1811: 431-440.
20. Njoroge, S. W., M. Laposata, W. Katrangi, and A. C. Seegmiller. 2012. DHA and EPA reverse cystic fi brosis-related FA abnormalities by suppressing FA desaturase expression and activity. J. Lipid Res. 53: 257-265.
21. Mihaylova, M. M., and R. J. Shaw. 2011. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13: 1016-1023.
22. Carling, D. 2004. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem. Sci. 29: 18-24.
23. Hardie, D. G. 2008. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond). 32 ( Suppl 4 ): S7-S12.
24. Kunzelmann, K., and A. Mehta. 2013. CFTR: a hub for kinases and crosstalk of cAMP and Ca2+. FEBS J. 280: 4417-4429.
25. Hallows, K. R., A. C. Fitch, C. A. Richardson, P. R. Reynolds, J. P. Clancy, P. C. Dagher, L. A. Witters, J. K. Kolls, and J. M. Pilewski. 2006. Up-regulation of AMP-activated kinase by dysfunctional cystic fi brosis transmembrane conductance regulator in cystic fi brosis airway epithelial cells mitigates excessive infl ammation. J. Biol. Chem. 281: 4231-4241.
26. Woods, A., S. R. Johnstone, K. Dickerson, F. C. Leiper, L. G. Fryer, D. Neumann, U. Schlattner, T. Wallimann, M. Carlson, and D. Carling. 2003. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13: 2004-2008.
27. Hawley, S. A., J. Boudeau, J. L. Reid, K. J. Mustard, L. Udd, T. P. Mäkelä, D. R. Alessi, and D. G. Hardie. 2003. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2: 28.
28. Hawley, S. A., D. A. Pan, K. J. Mustard, L. Ross, J. Bain, A. M. Edelman, B. G. Frenguelli, and D. G. Hardie. 2005. Calmodulindependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2: 9-19.
29. Antigny, F., C. Norez, F. Becq, and C. Vandebrouck. 2008. Calcium homeostasis is abnormal in cystic fi brosis airway epithelial cells but is normalized after rescue of F508del-CFTR. Cell Calcium. 43: 175-183.
30. Martins, J. R., P. Kongsuphol, E. Sammels, S. Dahimene, F. Aldehni, L. A. Clarke, R. Schreiber, H. de Smedt, M. D. Amaral, and K. Kunzelmann. 2011. F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fi brosis. Biochim. Biophys. Acta. 1812: 1385-1392.
31. Balghi, H., R. Robert, B. Rappaz, X. Zhang, A. Wohlhuter-Haddad, A. Evagelidis, Y. Luo, J. Goepp, P. Ferraro, P. Romeo, et al. 2011. Enhanced Ca2+ entry due to Orai1 plasma membrane insertion increases IL-8 secretion by cystic fi brosis airways. FASEB J. 25: 4274-4291.
32. Antigny, F., C. Norez, L. Dannhoffer, J. Bertrand, D. Raveau, P. Corbi, C. Jayle, F. Becq, and C. Vandebrouck. 2011. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fi brosis transmembrane conductance regulator channel dysfunction in cystic fi brosis. Am. J. Respir. Cell Mol. Biol. 44: 83-90.
33. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purifi cation of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
34. Rajan, S., G. Cacalano, R. Bryan, A. J. Ratner, C. U. Sontich, A. van Heerckeren, P. Davis, and A. Prince. 2000. Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fi brosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am. J. Respir. Cell Mol. Biol. 23: 304-312.
35. Zeitlin, P. L., L. Lu, J. Rhim, G. Cutting, G. Stetten, K. A. Kieffer, R. Craig, and W. B. Guggino. 1991. A cystic fi brosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am. J. Respir. Cell Mol. Biol. 4: 313-319.
36. Tokumitsu, H., H. Inuzuka, Y. Ishikawa, M. Ikeda, I. Saji, and R. Kobayashi. 2002. STO-609, a specifi c inhibitor of the Ca(2+)/calmodulin- dependent protein kinase kinase. J. Biol. Chem. 277: 15813-15818.
37. Green, M. F., K. A. Anderson, and A. R. Means. 2011. Characterization of the CaMKKbeta-AMPK signaling complex. Cell. Signal. 23: 2005-2012.
38. Handa, N., T. Takagi, S. Saijo, S. Kishishita, D. Takaya, M. Toyama, T. Terada, M. Shirouzu, A. Suzuki, S. Lee, et al. 2011. Structural basis for compound C inhibition of the human AMP-activated protein kinase alpha2 subunit kinase domain. Acta Crystallogr. D Biol. Crystallogr. 67: 480-487.
39. Zhou, G., R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, et al. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108: 1167-1174.
40. Corton, J. M., J. G. Gillespie, S. A. Hawley, and D. G. Hardie. 1995. 5-aminoimidazole-4-carboxamide ribonucleoside. A specifi c method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 229: 558-565.
41. Thomsen, K. F., M. Laposata, S. W. Njoroge, O. C. Umunakwe, W. Katrangi, and A. C. Seegmiller. 2011. Increased elongase 6 and Delta9-desaturase activity are associated with n-7 and n-9 fatty acid changes in cystic fi brosis. Lipids. 46: 669-677.
42. Katrangi, W., J. Lawrenz, A. C. Seegmiller, and M. Laposata. 2013. Interactions of linoleic and alpha-linolenic acids in the development of fatty acid alterations in cystic fi brosis. Lipids. 48: 333-342.
43. Mailhot, G., R. Rabasa-Lhoret, A. Moreau, Y. Berthiaume, and E. Levy. 2010. CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cells. PLoS ONE. 5: e10446.
44. Ribeiro, C. M., A. M. Paradiso, M. A. Carew, S. B. Shears, and R. C. Boucher. 2005. Cystic fi brosis airway epithelial Ca2+ i signaling: themechanism for the larger agonist-mediated Ca2+ i signals in human cystic fi brosis airway epithelia. J. Biol. Chem. 280: 10202-10209.
45. Ribeiro, C. M., A. M. Paradiso, U. Schwab, J. Perez-Vilar, L. Jones, W. O'Neal, and R. C. Boucher. 2005. Chronic airway infection/infl ammation induces a Ca2+i-dependent hyperinfl ammatory response in human cystic fi brosis airway epithelia. J. Biol. Chem. 280: 17798-17806.
46. Paradiso, A. M., C. M. Ribeiro, and R. C. Boucher. 2001. Polarized signaling via purinoceptors in normal and cystic fi brosis airway epithelia. J. Gen. Physiol. 117: 53-67.
47. Tabary, O., E. Boncoeur, R. de Martin, R. Pepperkok, A. Clement, C. Schultz, and J. Jacquot. 2006. Calcium-dependent regulation of NF-(kappa)B activation in cystic fi brosis airway epithelial cells. Cell. Signal. 18: 652-660.
48. Ludwig, S. A., and H. Sprecher. 1979. Substrate specifi city studies on the malonyl-CoA-dependent chain elongation of all-cis polyunsaturated fatty acids by rat liver microsomes. Arch. Biochem. Biophys. 197: 333-341.
49. Jakobsson, A., R. Westerberg, and A. Jacobsson. 2006. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog. Lipid Res. 45: 237-249.
50. Jäger, S., C. Handschin, J. St-Pierre, and B. M. Spiegelman. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA. 104: 12017-12022.
51. Lee, W. J., M. Kim, H. S. Park, H. S. Kim, M. J. Jeon, K. S. Oh, E. H. Koh, J. C. Won, M. S. Kim, G. T. Oh, et al. 2006. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem. Biophys. Res. Commun. 340: 291-295.
52. Vega, R. B., J. M. Huss, and D. P. Kelly. 2000. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20: 1868-1876.
53. Tang, C., H. P. Cho, M. T. Nakamura, and S. D. Clarke. 2003. Regulation of human delta-6 desaturase gene transcription: identifi cation of a functional direct repeat-1 element. J. Lipid Res. 44: 686-695.
54. McGee, S. L., B. J. van Denderen, K. F. Howlett, J. Mollica, J. D. Schertzer, B. E. Kemp, and M. Hargreaves. 2008. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes. 57: 860-867.
55. Mihaylova, M. M., D. S. Vasquez, K. Ravnskjaer, P. D. Denechaud, R. T. Yu, J. G. Alvarez, M. Downes, R. M. Evans, M. Montminy, and R. J. Shaw. 2011. Class IIa histone deacetylases are hormoneactivated regulators of FOXO and mammalian glucose homeostasis. Cell. 145: 607-621.
56. Bungard, D., B. J. Fuerth, P. Y. Zeng, B. Faubert, N. L. Maas, B. Viollet, D. Carling, C. B. Thompson, R. G. Jones, and S. L. Berger. 2010. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science. 329: 1201-1205.
57. Bartling, T. R., and M. L. Drumm. 2009. Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L35-L43.
58. Bartling, T. R., and M. L. Drumm. 2009. Oxidative stress causes IL8 promoter hyperacetylation in cystic fi brosis airway cell models. Am. J. Respir. Cell Mol. Biol. 40: 58-65.
59. Witters, P., L. Dupont, F. Vermeulen, M. Proesmans, D. Cassiman, P. Wallemacq, and K. De Boeck. 2013. Lung transplantation in cystic fi brosis normalizes essential fatty acid profi les. J. Cyst. Fibros. 12: 222-228.